Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision/version number was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.2 is now shown and the prior funding-status notice (v3.4.1) has been removed; no trial data, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedA government funding lapse notice appears on the page, and the revision number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check97 days agoChange DetectedThe changes are minor UI/metadata updates: a glossary toggle is shown, the QC status label now reads 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' note was removed, and the study revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.